The firms said that they will integrate Primaa's skin cancer testing algorithms with Gestalt's PathFlow digital pathology software platform.

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

Quest said it aims through the collaboration to streamline data management, improve data analytics, and personalize the experiences of its patients.

BioMérieux obtained 510 (k) clearance last year for its Vitek Reveal ID/AST system as part of its current five-year growth plan.

Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

NEW YORK – Blood-based testing continues to expand within neurology as researchers and clinicians pursue less expensive and less invasive tools for diagnosing and managing neurodegenerative disease.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK – Former Magellan Diagnostics CEO Amy Winslow pleaded guilty to violating the federal Food, Drug and Cosmetic Act in a case related to the malfunctioning of Magellan's lead-testing devices.

NEW YORK — NeoGenomics said on Monday that it has acquired New Jersey-based clinical laboratory Pathline. Financial and other terms of the deal were not disclosed. Founded in 2009, CLIA-certified ...

NEW YORK – Agilent Technologies said on Monday that it has received certification under the EU's In Vitro Diagnostic Regulation for the expanded use of a PD-L1 assay as a companion diagnostic test to ...